Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Clinical trial NCT00425802 · COMPLETED
Trial details
- NCT number
- NCT00425802
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-28
- Primary completion
- 2016-10-28
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.